SANCUSO

GRANISETRON · Cumberland Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for SANCUSO, covering 2008-09-12 to 2025-11-12. Get the full timeline:

Most recent: Clinical Trial Update: BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron [Phase 4]